Marketing-authorisation holder · United States
Epic Pharma LLC
36 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 36
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AK-PENTOLATE1% · Solution/drops | Cyclopentolate | United States | Not marketed | 1979 |
| AKBETA0.25% | 0.5% · Solution/drops | Levobunolol | United States | Not marketed | 1996 |
| AKPRO0.1% · Solution/drops | Dipivefrine | United States | Not marketed | 1995 |
| AKTOB0.3% · Solution/drops | Tobramycin | United States | Not marketed | 1996 |
| AMICAR250MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Aminocaproic acid | United States | Not marketed | 1964 |
| BETAXOLOL HYDROCHLORIDE10mg | 20mg · Tablet | Betaxolol | United States | Marketed | 1999 |
| BUCAPSOL10mg | 15mg | 5mg | 7.5mg · Capsule | Buspirone | United States | Marketed | 2025 |
| CAPASTAT SULFATE1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Capreomycin | United States | Not marketed | 1971 |
| CHLORAMPHENICOL0.5% · Solution/drops | Chloramphenicol | United States | Not marketed | 1981 |
| CILOSTAZOL100mg | 50mg · Tablet | Cilostazol | United States | Marketed | 2004 |
| COGENTIN1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Benzatropine | United States | Not marketed | 1959 |
| COR-OTICIN1.5%; 3.5mg base/ml · Suspension/drops | Hydrocortisone, Neomycin | United States | Not marketed | 1968 |
| DEMECLOCYCLINE HYDROCHLORIDE150mg | 300mg · Tablet | Demeclocycline | United States | Marketed | 2004 |
| DEXAMETHASONE SODIUM PHOSPHATE0.1% phosphate · Solution/drops | Dexamethasone | United States | Not marketed | 1976 |
| DOXERCALCIFEROL10mcg/5ml (2mcg/ml) | 2mcg/ml | 2mcg/ml (2mcg/ml) | 4mcg/2ml (2mcg/ml) · Injectable | Doxercalciferol | United States | Marketed | 2011 |
| EPINASTINE HYDROCHLORIDE0.05% · Solution/drops | Epinastine | United States | Marketed | 2011 |
| ERYTHRO-STATIN2% · Solution | Erythromycin | United States | Not marketed | 1996 |
| FAMOTIDINE PRESERVATIVE FREE10mg/ml · Injectable | Famotidine | United States | Marketed | 2001 |
| FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK)10mg/ml · Injectable | Famotidine | United States | Not marketed | 2002 |
| GLIMEPIRIDE1mg | 2mg | 3mg | 4mg | 6mg | 8mg · Tablet | Glimepiride | United States | Marketed | 2005 |
| INNOVAR2.5mg/ml; 0.05mg base/ml · Injectable | Droperidol, Fentanyl | United States | Not marketed | |
| IVERMECTIN3mg | 6mg · Tablet | Ivermectin | United States | Marketed | 2014 |
| KLAYESTA100,000 units/gm · Powder | Nystatin | United States | Marketed | 2018 |
| METHOTREXATE SODIUM0.154mg/ml; 0.92mg/ml; 0.184mg/ml; 0.2mg/ml; 0.38mg/ml; 2.1mg/ml; 7.14mg/ml; 0.42mg/ml · Solution | Calcium chloride, Dextrose, Glutathione disulfide, Magnesium chloride, Potassium chloride, Bicarbonate, Sodium chloride, Sodium phosphate | United States | Not marketed | 1991 |
| MOLINDONE HYDROCHLORIDE10mg | 25mg | 5mg · Tablet | Molindone | United States | Marketed | 2015 |